Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Work In Process (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Work In Process for 15 consecutive years, with $63.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Work In Process rose 11.13% year-over-year to $63.3 million, compared with a TTM value of $63.3 million through Dec 2025, up 11.13%, and an annual FY2025 reading of $63.3 million, up 11.13% over the prior year.
  • Work In Process was $63.3 million for Q4 2025 at Orthofix Medical, up from $61.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $63.3 million in Q4 2025 and bottomed at $14.5 million in Q1 2022.
  • Average Work In Process over 5 years is $41.1 million, with a median of $55.1 million recorded in 2023.
  • The sharpest move saw Work In Process fell 5.48% in 2022, then soared 303.9% in 2023.
  • Year by year, Work In Process stood at $15.1 million in 2021, then rose by 27.47% to $19.2 million in 2022, then surged by 178.08% to $53.5 million in 2023, then rose by 6.37% to $56.9 million in 2024, then increased by 11.13% to $63.3 million in 2025.
  • Business Quant data shows Work In Process for OFIX at $63.3 million in Q4 2025, $61.0 million in Q3 2025, and $61.4 million in Q2 2025.